Company Overview and News

Eastmain Announces Conference Call to Discuss Eau Claire PEA Expected May 23, 2018

2018-05-18 globenewswire
TORONTO, May 18, 2018 (GLOBE NEWSWIRE) -- Eastmain Resources Inc. (“Eastmain” or the “Company”) (TSX:ER) (OTCQX:EANRF) expects to announce results of its Preliminary Economic Assessment (“PEA”) on its 100%-owned Eau Claire project located in James Bay, Quebec on Wednesday, May 23, 2018 before market open.

Roth IRAs From A Retiree's Perspective - Great For The Young And Young At Heart

2018-05-18 seekingalpha
Roth IRAs are going to be the most fun to write about of any of the postings in this series. There are just so many benefits to Roth accounts that they are fun to think about. It isn't just about taxes, but they're good place to start.

International Demand Bullish For Gold

2018-05-17 seekingalpha
Gold has not performed especially well as of late, especially when compared to other assets such as the S&P 500.

Is It Time For Precious Metals Equities?  What About Barrick?

2018-05-17 seekingalpha
Precious metals stocks peaked in 2011, then bottomed in late 2015, ahead of the broader bottom in commodity equities.

PRESS DIGEST-Canada-May 17

2018-05-17 reuters
May 17 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

Brazil Minerals, Inc. Strikes Gold in the Paracatu Project

2018-05-16 globenewswire
PASADENA, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Brazil Minerals, Inc. (OTC:BMIX) (the "Company" or "Brazil Minerals") announced today that its subsidiary, Jupiter Gold Corporation (“Jupiter Gold”), is advancing the initial drilling campaign of its Paracatu Project and already struck gold in multiple holes drilled. Gold particles were obtained and confirmed in pan concentrates in samples taken.

Barrick Announces Conversion of Pueblo Viejo to Natural Gas

2018-05-15 zacks
Barrick Gold Corporation (ABX - Free Report) declared that the operator of the Pueblo Viejo mine — Pueblo Viejo Dominicana Corporation (“PVDC”) — has inked a 10-year natural gas supply contract with AES Andres DR, S.A. in the Dominican Republic. The move will enable the conversion of the Quisqueya I power generation facility to natural gas from heavy fuel oil. Notably, PVDC is a joint venture between Barrick Gold and Goldcorp Inc.

Trade of the Day: Goldcorp Inc. (USA) (GG) | InvestorPlace

2018-05-14 investorplace
To receive further updates on this Goldcorp Inc. (USA) (NYSE:GG) trade as well as an alert when it’s time to take profits, sign up for a risk-free trial of Power Options Weekly today.

Barrick Announces Conversion of Pueblo Viejo Power Plant to Natural Gas

2018-05-14 globenewswire
TORONTO, May 14, 2018 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (NYSE:ABX) (TSX:ABX) (Barrick or the “Company”) today announced that Pueblo Viejo Dominicana Corporation (“PVDC”), operator of the Pueblo Viejo mine, has signed a 10-year natural gas supply contract with AES Andres DR, S.A. in the Dominican Republic that will enable the conversion of the Quisqueya I power generation facility from heavy fuel oil to natural gas.

Focusing On Gold's Resilient Base

2018-05-11 seekingalpha
Gold trended higher in early April due to trade tensions between the U.S. and China, prospects of airstrikes on Syria, and heightened inflation expectations following a higher than expected March Producers Price Index (PPI)1 and a 2.1% annual rise in the core Consumer Price Index2. Gold topped at $1,365 per ounce on March 11. This level has been the proverbial price ceiling for gold since 2014.

Now May Be Time to Buy Gold as Geopolitical Tensions Soar

2018-05-10 247wallst
If you think Iran is the only current hot spot, all you need to do is look around the world, and there are numerous places where things could flare up. While the situation on the Korean Peninsula looks better than any time in recent history, the North Koreans have been known to bait and switch, and we still face the potential for trouble in Syria, Afghanistan and across the Middle East.

Goldcorp's (GG) Q1 Earnings and Revenues Miss Estimates

2018-04-30 zacks
Goldcorp Inc. (GG - Free Report) reported net earnings of $67 million or 8 cents per share for first-quarter 2018, down from $170 million or 20 cents recorded a year ago. Earnings per share missed the Zacks Consensus Estimate of 11 cents. Goldcorp recorded revenues of $846 million in the first quarter, down roughly 4.1% year over year. The figure also missed the Zacks Consensus Estimate of $868.5 million.

A Not-So-Golden Quarter for Goldcorp Inc. (USA) Stock

2018-04-28 investorplace
With all the recent uncertainty and increased volatility, gold has been shining pretty bright over the last few quarters. And, in theory, that should benefit the various miners of the precious metal. But looking at the latest results from low-cost leader Goldcorp (NYSE:GG) shows that higher gold prices don’t necessarily equal improving results, as GG stock managed to report a big miss.

How Was the Q1 Earnings Season for Gold Mining ETFs?

2018-04-27 zacks
The gold mining space remained moderate after mixed-to-downbeat earnings reports for the first quarter. Below we highlight Q1 earnings results of Barrick Gold Corp (ABX - Free Report) , Goldcorp Inc. (GG - Free Report) and Newmont Mining Corp. (NEM - Free Report) . Among the trio, Barrick was the first to report earnings (read: Why Gold Mining ETFs Are Rallying).

Related Articles

TROV: TrovaGene Analysis and Research Report

15m - Asif

BUSINESS TrovaGene is a clinical-stage, precision medicine oncology therapeutics company. The company's primary focus is to develop oncology therapeutics for improved cancer care and to optimize drug development by leveraging its proprietary Precision Cancer Monitoring® (“PCM”) technology in tumor genomics. The company's lead drug candidate, PCM-075, is a Polo-like Kinase 1 (“PLK1”) selective adenosine triphosphate (“ATP”) competitive inhibitor. PCM-075 has shown preclinical antitumor activity as a single agent and synergy in combination with more than ten different chemotherapeutics and targeted therapies, such as Zytiga® (abiraterone acetate), Beleodaq® (belinostat), Quizartinib (AC220), a development stage FLT3 inhibitor, and Velcade® (bortezomib) in Acute Myeloid Leukemia (“AML”), metastatic Castration-Resistant Prostate Cancer (“mCRPC”) and other hematologic and solid tumor cancers. On March 15, 2017, the company announced the licensing of PCM-075, a PLK1 inhibitor...

SGMO: Sangamo BioSciences Analysis and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics Analysis and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

CUSIP: 380956409